An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)

Published:2020-02-25 Issue:8 Volume:9 Page:2774-2790
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Jiang Wen¹,Zhu Dandan¹,Wang Chenghe¹,Zhu Yu¹^ORCID

Affiliation:

1. Department of Urology Ruijin Hospital Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Natural Science Foundation of Shanghai

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.2942

Reference57 articles.

1. Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

2. Management of Muscle-Invasive Urothelial Cancer and the Emerging Role of Immunotherapy in Advanced Urothelial Cancer

3. Management of metastatic bladder cancer

4. Mechanisms of BCG immunotherapy and its outlook for bladder cancer

5. The mechanism of action of BCG therapy for bladder cancer—a current perspective

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Increased UBD Is a Potential Diagnostic and Prognostic Biomarker in Glioma;Environmental Toxicology;2024-08-18

2. Prediction of immunotherapy response of bladder cancer with a pyroptosis-related signature indicating tumor immune microenvironment;Frontiers in Pharmacology;2024-06-25

3. Silencing immune-infiltrating biomarker CCDC80 inhibits malignant characterization and tumor formation in gastric cancer;BMC Cancer;2024-06-13

4. Transcriptome Analysis Reveals Distinct Patterns Between the Invasive and Noninvasive Pituitary Neuroendocrine Tumors;Journal of the Endocrine Society;2024-03-01

5. Identification of an inflammation-related risk signature for prognosis and immunotherapeutic response prediction in bladder cancer;Scientific Reports;2024-01-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3